Skip to content

Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents

Parent Mentors to Improve Adherence to Type I Diabetes Care Regimen in Adolescents

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03199716
Enrollment
27
Registered
2017-06-27
Start date
2014-09-30
Completion date
2017-03-23
Last updated
2019-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1

Brief summary

The study aim is to determine if parent mentors can improve adherence to the intensive multiple daily injection regimen (MDI) or the insulin pump therapy, through monitoring the frequency of blood glucose measurements. Researchers are also trying to determine if the parent mentors can improve glycemic control, which is measured through HbA1c. The study hypothesis is that trained parent mentors can help families with children who have poorly controlled T1DM improve adherence to their diabetes regimen and improve their metabolic control.

Detailed description

The study aim is to determine if parent mentors can improve adherence to the intensive multiple daily injection regimen (MDI) or the insulin pump therapy, through monitoring the frequency of blood glucose measurements. Researchers are also trying to determine if the parent mentors can improve glycemic control, which is measured through HbA1c. Diabetic knowledge, responsibility for diabetes care, degree of diabetes related family conflicts, and major complications of diabetes will also be collected during the patient's routine clinic visit. The study hypothesis is that trained parent mentors can help families with children who have poorly controlled T1DM improve adherence to their diabetes regimen and improve their metabolic control.

Interventions

Parent mentors are to meet up with their assigned intervention group 4 times in 1 year and call the families monthly to document any diabetic complications

Sponsors

Children's Miracle Network
CollaboratorOTHER
University of California, Davis
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
10 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

for mentee families: * Residing within 60 miles of a Parent Mentor * Child diagnosed with T1DM greater than or equal to 1 year at the start of our study's data collection (February 2015) * On multiple daily injection regime or insulin pump therapy * Mean HbA1c between 8.5 - 12.5% over the last 2 clinic visits Inclusion Criteria for parent mentors: * Child diagnosed with T1DM greater than or equal to 2 years at the start of our study's data collection * Compliant with suggestions made by the diabetes care team * Mean HbA1c less than or equal to 8% over the last 2 clinic visits * No episodes of diabetic ketoacidosis, aside from initial episode at diagnosis, if applicable

Design outcomes

Primary

MeasureTime frameDescription
Daily frequency of blood glucose monitoring (BGM)up to 12 monthsNumber of glucose monitoring events per day

Secondary

MeasureTime frameDescription
HbA1c levelsup to 12 monthsValues of HbA1c in blood

Other

MeasureTime frameDescription
Diabetes knowledgeup to 12 monthsScore measured by Diabetes Numeracy Test (DNT-15)
Degree of diabetes related family conflictsup to 12 monthsScore based on Questionnaire (r-DFCS)
Responsibility for diabetes careup to 12 monthsScore based on Diabetes Family Responsibility Questionnaire (DFRQ)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026